Colitis and Colorectal Cancer
Inflammatory bowel diseases (IBD) are accompanied by an increased risk of developing colitis-associated carcinoma (CAC). These tumors are one of the most important causes of morbidity and mortality in patients with IBD and distinctly differ from sporadic colorectal cancer in their biology and underl...
Gespeichert in:
| Veröffentlicht in: | Digestive diseases (Basel) 2012-01, Vol.30 (5), p.469-476 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 476 |
|---|---|
| container_issue | 5 |
| container_start_page | 469 |
| container_title | Digestive diseases (Basel) |
| container_volume | 30 |
| creator | Foersch, Sebastian Waldner, Maximilian J. Neurath, Markus F. |
| description | Inflammatory bowel diseases (IBD) are accompanied by an increased risk of developing colitis-associated carcinoma (CAC). These tumors are one of the most important causes of morbidity and mortality in patients with IBD and distinctly differ from sporadic colorectal cancer in their biology and underlying mechanisms. First, this review discusses risk factors for the development of CAC and summarizes some of the most important genetic alterations and molecular pathways involved in inflammatory carcinogenesis. Then, new endoscopic techniques, such as chromoendoscopy and confocal laser endomicroscopy, and their contribution to surveillance and early detection of CAC are presented. Last, we briefly address different types of concepts for prevention (i.e. anti-inflammatory agents) and treatment (i.e. surgical resection) of CAC and give an outlook on this important aspect of IBD. |
| doi_str_mv | 10.1159/000341692 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000341692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1124751202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-325f5146405a5d55e8c861d732971221d77d50779967516d50298824f1d7edcb3</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhM1L9EEP3AH1CIfA7tqO7SOKeEmVuMA5ch0HBdKm2OmBf1-jPk470nwz0g5jlwj3iNI8AAAXmBs6YiPOUQOR4PqYDVEQZkYrecImRum9R3jKhkBSZaQkH7BRjN8AqUnl52xAHEFzoCG7Lrq26Zs4tctqmnQXvOttOy3s0vlwwc5q20Y_2d0x-3x--ihes9n7y1vxOMucANVnnGQtUeQCpJWVlF47nWOlOBmFREmpSoJSxuRKYp40Ga1J1MnxlZvzMbvd9q5C97v2sS8XTXS-be3Sd-tYIpJISQJK6N0WdaGLMfi6XIVmYcNfiVD-T1Uepkrsza52PV_46kDu30_A1Rb4seHLhwOwy28API5jAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1124751202</pqid></control><display><type>article</type><title>Colitis and Colorectal Cancer</title><source>Karger Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Foersch, Sebastian ; Waldner, Maximilian J. ; Neurath, Markus F.</creator><creatorcontrib>Foersch, Sebastian ; Waldner, Maximilian J. ; Neurath, Markus F.</creatorcontrib><description>Inflammatory bowel diseases (IBD) are accompanied by an increased risk of developing colitis-associated carcinoma (CAC). These tumors are one of the most important causes of morbidity and mortality in patients with IBD and distinctly differ from sporadic colorectal cancer in their biology and underlying mechanisms. First, this review discusses risk factors for the development of CAC and summarizes some of the most important genetic alterations and molecular pathways involved in inflammatory carcinogenesis. Then, new endoscopic techniques, such as chromoendoscopy and confocal laser endomicroscopy, and their contribution to surveillance and early detection of CAC are presented. Last, we briefly address different types of concepts for prevention (i.e. anti-inflammatory agents) and treatment (i.e. surgical resection) of CAC and give an outlook on this important aspect of IBD.</description><identifier>ISSN: 0257-2753</identifier><identifier>ISBN: 9783318022421</identifier><identifier>ISBN: 331802242X</identifier><identifier>EISSN: 1421-9875</identifier><identifier>EISBN: 3318022438</identifier><identifier>EISBN: 9783318022438</identifier><identifier>DOI: 10.1159/000341692</identifier><identifier>PMID: 23108302</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Animals ; Antineoplastic Agents ; Cell Transformation, Neoplastic - genetics ; Cell Transformation, Neoplastic - metabolism ; Colitis - complications ; Colitis - diagnosis ; Colitis - drug therapy ; Colitis - genetics ; Colitis - surgery ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - drug therapy ; Colorectal Neoplasms - etiology ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - surgery ; Endoscopy - instrumentation ; Endoscopy - methods ; Humans ; Immunology ; Mice ; Mutation ; Risk Factors</subject><ispartof>Digestive diseases (Basel), 2012-01, Vol.30 (5), p.469-476</ispartof><rights>2012 S. Karger AG, Basel</rights><rights>Copyright © 2012 S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-325f5146405a5d55e8c861d732971221d77d50779967516d50298824f1d7edcb3</citedby><cites>FETCH-LOGICAL-c407t-325f5146405a5d55e8c861d732971221d77d50779967516d50298824f1d7edcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23108302$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Foersch, Sebastian</creatorcontrib><creatorcontrib>Waldner, Maximilian J.</creatorcontrib><creatorcontrib>Neurath, Markus F.</creatorcontrib><title>Colitis and Colorectal Cancer</title><title>Digestive diseases (Basel)</title><addtitle>Dig Dis</addtitle><description>Inflammatory bowel diseases (IBD) are accompanied by an increased risk of developing colitis-associated carcinoma (CAC). These tumors are one of the most important causes of morbidity and mortality in patients with IBD and distinctly differ from sporadic colorectal cancer in their biology and underlying mechanisms. First, this review discusses risk factors for the development of CAC and summarizes some of the most important genetic alterations and molecular pathways involved in inflammatory carcinogenesis. Then, new endoscopic techniques, such as chromoendoscopy and confocal laser endomicroscopy, and their contribution to surveillance and early detection of CAC are presented. Last, we briefly address different types of concepts for prevention (i.e. anti-inflammatory agents) and treatment (i.e. surgical resection) of CAC and give an outlook on this important aspect of IBD.</description><subject>Animals</subject><subject>Antineoplastic Agents</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>Colitis - complications</subject><subject>Colitis - diagnosis</subject><subject>Colitis - drug therapy</subject><subject>Colitis - genetics</subject><subject>Colitis - surgery</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Colorectal Neoplasms - etiology</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - surgery</subject><subject>Endoscopy - instrumentation</subject><subject>Endoscopy - methods</subject><subject>Humans</subject><subject>Immunology</subject><subject>Mice</subject><subject>Mutation</subject><subject>Risk Factors</subject><issn>0257-2753</issn><issn>1421-9875</issn><isbn>9783318022421</isbn><isbn>331802242X</isbn><isbn>3318022438</isbn><isbn>9783318022438</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtPwzAQhM1L9EEP3AH1CIfA7tqO7SOKeEmVuMA5ch0HBdKm2OmBf1-jPk470nwz0g5jlwj3iNI8AAAXmBs6YiPOUQOR4PqYDVEQZkYrecImRum9R3jKhkBSZaQkH7BRjN8AqUnl52xAHEFzoCG7Lrq26Zs4tctqmnQXvOttOy3s0vlwwc5q20Y_2d0x-3x--ihes9n7y1vxOMucANVnnGQtUeQCpJWVlF47nWOlOBmFREmpSoJSxuRKYp40Ga1J1MnxlZvzMbvd9q5C97v2sS8XTXS-be3Sd-tYIpJISQJK6N0WdaGLMfi6XIVmYcNfiVD-T1Uepkrsza52PV_46kDu30_A1Rb4seHLhwOwy28API5jAw</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Foersch, Sebastian</creator><creator>Waldner, Maximilian J.</creator><creator>Neurath, Markus F.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120101</creationdate><title>Colitis and Colorectal Cancer</title><author>Foersch, Sebastian ; Waldner, Maximilian J. ; Neurath, Markus F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-325f5146405a5d55e8c861d732971221d77d50779967516d50298824f1d7edcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Antineoplastic Agents</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>Colitis - complications</topic><topic>Colitis - diagnosis</topic><topic>Colitis - drug therapy</topic><topic>Colitis - genetics</topic><topic>Colitis - surgery</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Colorectal Neoplasms - etiology</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - surgery</topic><topic>Endoscopy - instrumentation</topic><topic>Endoscopy - methods</topic><topic>Humans</topic><topic>Immunology</topic><topic>Mice</topic><topic>Mutation</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Foersch, Sebastian</creatorcontrib><creatorcontrib>Waldner, Maximilian J.</creatorcontrib><creatorcontrib>Neurath, Markus F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Foersch, Sebastian</au><au>Waldner, Maximilian J.</au><au>Neurath, Markus F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colitis and Colorectal Cancer</atitle><jtitle>Digestive diseases (Basel)</jtitle><addtitle>Dig Dis</addtitle><date>2012-01-01</date><risdate>2012</risdate><volume>30</volume><issue>5</issue><spage>469</spage><epage>476</epage><pages>469-476</pages><issn>0257-2753</issn><eissn>1421-9875</eissn><isbn>9783318022421</isbn><isbn>331802242X</isbn><eisbn>3318022438</eisbn><eisbn>9783318022438</eisbn><abstract>Inflammatory bowel diseases (IBD) are accompanied by an increased risk of developing colitis-associated carcinoma (CAC). These tumors are one of the most important causes of morbidity and mortality in patients with IBD and distinctly differ from sporadic colorectal cancer in their biology and underlying mechanisms. First, this review discusses risk factors for the development of CAC and summarizes some of the most important genetic alterations and molecular pathways involved in inflammatory carcinogenesis. Then, new endoscopic techniques, such as chromoendoscopy and confocal laser endomicroscopy, and their contribution to surveillance and early detection of CAC are presented. Last, we briefly address different types of concepts for prevention (i.e. anti-inflammatory agents) and treatment (i.e. surgical resection) of CAC and give an outlook on this important aspect of IBD.</abstract><cop>Basel, Switzerland</cop><pmid>23108302</pmid><doi>10.1159/000341692</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0257-2753 |
| ispartof | Digestive diseases (Basel), 2012-01, Vol.30 (5), p.469-476 |
| issn | 0257-2753 1421-9875 |
| language | eng |
| recordid | cdi_crossref_primary_10_1159_000341692 |
| source | Karger Journals; MEDLINE; Alma/SFX Local Collection |
| subjects | Animals Antineoplastic Agents Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - metabolism Colitis - complications Colitis - diagnosis Colitis - drug therapy Colitis - genetics Colitis - surgery Colorectal Neoplasms - diagnosis Colorectal Neoplasms - drug therapy Colorectal Neoplasms - etiology Colorectal Neoplasms - genetics Colorectal Neoplasms - surgery Endoscopy - instrumentation Endoscopy - methods Humans Immunology Mice Mutation Risk Factors |
| title | Colitis and Colorectal Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A09%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colitis%20and%20Colorectal%20Cancer&rft.jtitle=Digestive%20diseases%20(Basel)&rft.au=Foersch,%20Sebastian&rft.date=2012-01-01&rft.volume=30&rft.issue=5&rft.spage=469&rft.epage=476&rft.pages=469-476&rft.issn=0257-2753&rft.eissn=1421-9875&rft.isbn=9783318022421&rft.isbn_list=331802242X&rft_id=info:doi/10.1159/000341692&rft_dat=%3Cproquest_cross%3E1124751202%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&rft.eisbn=3318022438&rft.eisbn_list=9783318022438&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1124751202&rft_id=info:pmid/23108302&rfr_iscdi=true |